He is the first Associate Director for Oncology Research in the Institute for Pharmacogenomics and Individualized Therapy. He holds appointments in the UNC School of Medicine and the UNC Lineberger Comprehensive Cancer Center. Dr. Innocenti obtained his MD from the University of Pisa, Pisa, Italy, followed by residencies in Clinical Pharmacology and Oncology. He has a PhD in Pharmacology, Toxicology, and Chemotherapy. He joined UNC in January 2011 after twelve years of research in cancer pharmacogenetics at the University of Chicago. At the same institution, he directed the Pharmacology Course for the Pritzker School of Medicine for the seven years.